William Hoffman, Director at Inari Medical, Inc. (NARI), sold 49,100 shares at $59.62 ($3.0M) on 2023-11-15, disclosed to the SEC on 2023-11-17.
Scheduled sale ($3.0M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.62 | 900 | $54K | 1.8% |
| 2 | $59.72 | 1,372 | $82K | 2.7% |
| 3 | $59.72 | 1,372 | $82K | 2.7% |
| 4 | $60.98 | 2,369 | $144K | 4.8% |
| 5 | $60.98 | 2,369 | $144K | 4.8% |
| 6 | $61.05 | 4,295 |
| $262K |
| 8.7% |
| 7 | $61.05 | 4,295 | $262K | 8.7% |
| 8 | $61.54 | 6,731 | $414K | 13.8% |
| 9 | $61.54 | 6,731 | $414K | 13.8% |
| 10 | $61.57 | 9,333 | $575K | 19.1% |
| 11 | $61.57 | 9,333 | $575K | 19.1% |
| Total | $61.27 avg | 49,100 | $3.0M | 100% |
| Filing → |
| NARI | SELL | 2024-11-20 | $5.5M | — | Filing → |
| NARI | SELL | 2024-10-31 | $2.0M | — | Filing → |
| NARI | SELL | 2024-10-18 | $3.6M | — | Filing → |